These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 14767797

  • 1. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
    Gerbershagen MU, Wappler F, Fiege M, Weisshorn R, Kolodzie K, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F, Roewer N, Köchling A, Scholz J, Löscher W, Steinfath M.
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [Abstract] [Full Text] [Related]

  • 8. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
    Weisshorn R, Wappler F, Fiege M, Gerbershagen M, Schulte Am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
    [Abstract] [Full Text] [Related]

  • 9. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E, Koob M, Anetseder M, Schoemig P, Krauspe R, Hogrefe G, Engelhardt W.
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [Abstract] [Full Text] [Related]

  • 10. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT, Nelson TE.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
    Bendahan D, Guis S, Monnier N, Kozak-Ribbens G, Lunardi J, Ghattas B, Mattei JP, Cozzone PJ.
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
    [Abstract] [Full Text] [Related]

  • 13. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
    Hackl W, Winkler M, Mauritz W, Steinbereithner K.
    Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
    [Abstract] [Full Text] [Related]

  • 14. [Ryanodine-induced contractures for the diagnosis of malignant hyperthermia susceptibility].
    Lenzen C, Roewer N, Scholz J, Rumberger E, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):459-63. PubMed ID: 1786306
    [Abstract] [Full Text] [Related]

  • 15. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Fiege M, Wappler F, Scholz J, Weisshorn R, von Richthofen V, Schulte am Esch J.
    J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326
    [Abstract] [Full Text] [Related]

  • 16. [High purity ryanodine for in vitro diagnosis of malignant hyperthermia].
    Wappler F, Roewer N, Lenzen C, Scholz J, Steinfath M, Rumberger R, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):427-31. PubMed ID: 8297948
    [Abstract] [Full Text] [Related]

  • 17. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
    Wappler F, Scholz J, Oppermann S, von Richthofen V, Steinfath M, Schulte am Esch J.
    J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
    [Abstract] [Full Text] [Related]

  • 18. In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swine.
    Gerbershagen MU, Wappler F, Fiege M, Weilsshorn R, Alberts PA, von Breunig F, Schulte am Esch J.
    Eur J Anaesthesiol; 2002 Feb; 19(2):135-40. PubMed ID: 11999597
    [Abstract] [Full Text] [Related]

  • 19. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
    Mortier W, Breucking E.
    Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
    [Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.
    Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Kolodzie K, Schulte am Esch J.
    Eur J Anaesthesiol; 2005 Apr; 22(4):283-8. PubMed ID: 15892406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.